Welcome to runprofits.com Registration

Major Biotech Win: AstraZeneca's EU approval for Imfinzi is a clear, high-value catalyst.
Strategic De-risking: AFC Energy executed a pivotal JV, creating a clear commercial path.
Forward-Looking Headwinds: The market punished MJ Gleeson for its FY26 profit warning.

You have arrived here because you have paid a subscription to one of runprofits.com memberships . We need you to register your membership and choose a username, password

Once you have filled out the simple form, you will receive a final email to verify your details and a link to sign-in.

This makes sure the we keep our community safe by knowing all of our members are bona fide and that we satisfy the GDPR regulations to keep you safe.

You can check the status of your membership and billing at any time under the My Account Menu above - choose My Billing to view your payment history and status. You can also cancel your membership at any time from this option

Paid subscription members can comment on articles and participate in the discussion groups on runprofits.com : the username you choose below will be the name under which you post. Please choose a username accordingly and refer to our Terms and Conditions and Privacy Policy should you need further guidance.

I am delighted you have chosen to join us and truly hope the content and community you find here will help transform your journey in the financial markets.